Virtual Reality Relaxation for Addiction Inpatients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04293978|
Recruitment Status : Suspended (Recruitment and intervention provision paused due to COVID-19 situation. Planned to resume.)
First Posted : March 3, 2020
Last Update Posted : February 18, 2021
|Condition or disease||Intervention/treatment||Phase|
|Addiction||Behavioral: CalmPlace||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||Single-arm, with immediate effects of interest. Varying number of intervention uses across participants.|
|Masking:||None (Open Label)|
|Official Title:||Virtual Reality Relaxation at an Adolescent Addiction Inpatient Ward: A Single-arm Pilot Trial|
|Actual Study Start Date :||February 21, 2020|
|Estimated Primary Completion Date :||June 30, 2021|
|Estimated Study Completion Date :||December 31, 2021|
Experimental: Virtual Reality relaxation
Participants may request to use the application at any time during their stay at the ward, as many times as they wish. Participants sign in using an anonymous study ID and sessions (and outcomes) are automatically logged by the device to this ID.
Self-contained VR application allowing the user to build and custom a relaxation session, with options to vary session length (9-20 minutes), music/sound, relaxation exercises, and specific nature environment (three available) including time of day and events (e.g. rain). Delivered using an Oculus Go devices in kiosk-mode.
- Change from baseline in general well-being [ Time Frame: Change from baseline (start of session) to immediately after the intervention ]Rated 0-100 using a visual analogue scale with smiley-type anchors (higher score is better outcome).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04293978
|Maria Ungdom Heldygnsvård|
|Stockholm, Sweden, 18354|
|Principal Investigator:||Philip Lindner, PhD||Karolinska Institutet|